Organon (OGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Organon (OGN) stock dropped 13% after the company's Q1 results indicated its plans to cut dividends to $0.02/share amid a ...

Organon stock cut their dividend by over 90%. There are lessons here for all income investors. Click here to find out what ...

Pharmaceutical company Organon (NYSE:OGN) reported in Q1 CY2025, but sales fell by 6.7% year on year to $1.51 billion. Its ...

When a stock falls steadily on no news, that is a hint to avoid the company. Organon (OGN), a spin-off from Merck (MRK), continued to trade at a discount after posting results. The firm cut its ...

BofA analyst Jason Gerberry lowered the firm’s price target on Organon (OGN) to $10 from $11 and keeps an Underperform rating ...

The Jersey City, N.J., pharmaceutical company cut its quarterly dividend to 2 cents a share, down from the prior 28 cents a share. Chief Executive Kevin Ali said the company reset its ...

According to TipRanks.com, Anderson is a 4-star analyst with an average return of 11.4% and a 72.4% success rate. Anderson covers the Healthcare sector, focusing on stocks such as Mineralys ...

The DJS Law Group announces that it is investigating claims on behalf of investors of Organon & Co. ("Organon" or "the Company") (NYSE: OGN) for violations of the securities laws. INVESTIGATION ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...